Metabolic and analytic considerations in the design of immunoassays.
D000639:Amitriptyline / Q000032:analysis; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000032:analysis; D000242:Cyclic AMP / Q000032:analysis; D003687:Dehydroepiandrosterone / Q000032:analysis; D013196:Dihydrotestosterone / Q000032:analysis; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D009661:Nortriptyline / Q000032:analysis; D004364:Pharmaceutical Preparations / Q000032:analysis / Q000378:metabolism*; D010879:Piperazines / Q000032:analysis; D011284:Pregnenolone / Q000032:analysis; D013739:Testosterone / Q000032:analysis
D000889:Anti-Arrhythmia Agents; D004364:Pharmaceutical Preparations; D010879:Piperazines; D013196:Dihydrotestosterone; D000639:Amitriptyline; D013739:Testosterone; D003687:Dehydroepiandrosterone; D011284:Pregnenolone; D009661:Nortriptyline; D000242:Cyclic AMP; C019280:bucainide